Total Payments
$11,296
2024 Payments
$1,752
Companies
63
Transactions
655
Medicare Patients
3,711
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$10,968 (97.1%)
Education$248.15 (2.2%)
Consulting$80.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,968 | 647 | 97.1% |
| Education | $248.15 | 6 | 2.2% |
| Consulting Fee | $80.00 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,726 | 90 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,003 | 61 | $0 (2024) |
| Janssen Biotech, Inc. | $969.50 | 66 | $0 (2024) |
| PFIZER INC. | $816.07 | 68 | $0 (2024) |
| UCB, Inc. | $596.31 | 37 | $0 (2024) |
| ABBVIE INC. | $519.66 | 36 | $0 (2024) |
| Lilly USA, LLC | $500.19 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $409.41 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $382.23 | 16 | $0 (2024) |
| Celgene Corporation | $323.60 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,752 | 97 | Amgen Inc. ($288.46) |
| 2023 | $1,641 | 87 | Amgen Inc. ($292.69) |
| 2022 | $909.68 | 56 | Janssen Biotech, Inc. ($180.98) |
| 2021 | $12.86 | 1 | Janssen Biotech, Inc. ($12.86) |
| 2020 | $379.10 | 27 | E.R. Squibb & Sons, L.L.C. ($65.90) |
| 2019 | $2,207 | 151 | Amgen Inc. ($305.90) |
| 2018 | $1,815 | 127 | Amgen Inc. ($319.09) |
| 2017 | $2,579 | 109 | Amgen Inc. ($433.38) |
All Payment Transactions
655 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ORTHOPEDICS | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.83 | General |
| 11/19/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 09/26/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Oncology / Rare Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 978 | 54,521 | $1.6M | $407,682 |
| 2022 | 17 | 892 | 67,280 | $1.9M | $477,724 |
| 2021 | 19 | 933 | 61,468 | $1.7M | $525,954 |
| 2020 | 19 | 908 | 8,108 | $800,257 | $200,254 |
Total Patients
3,711
Total Services
191,377
Medicare Billing
$1.6M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 13 | 45,200 | $727,720 | $175,798 | 24.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 59 | 5,640 | $366,600 | $100,923 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 612 | $223,515 | $62,536 | 28.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 63 | 225 | $67,937 | $15,614 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 189 | $47,293 | $13,972 | 29.5% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2023 | 17 | 1,665 | $62,371 | $12,069 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 60 | $29,100 | $8,599 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $17,050 | $4,005 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $16,698 | $3,717 | 22.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 77 | 277 | $24,598 | $3,254 | 13.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $8,280 | $1,985 | 24.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 56 | 254 | $3,839 | $1,472 | 38.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $2,289 | $1,151 | 50.3% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 17 | 25 | $4,546 | $1,127 | 24.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 36 | 87 | $2,474 | $780.88 | 31.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $648.00 | $611.46 | 94.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 38 | 164 | $273.88 | $70.08 | 25.6% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 19 | 56,840 | $915,124 | $254,381 | 27.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 56 | 5,400 | $474,475 | $91,874 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 639 | $233,376 | $65,851 | 28.2% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 17 | 1,920 | $71,923 | $15,284 | 21.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 54 | 202 | $56,069 | $13,579 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 141 | $35,282 | $10,207 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 64 | $31,040 | $8,601 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $17,600 | $4,282 | 24.3% |
About Dr. Jeff Chung, M.D
Dr. Jeff Chung, M.D is a Rheumatology healthcare provider based in Emerson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083684088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeff Chung, M.D has received a total of $11,296 in payments from pharmaceutical and medical device companies, with $1,752 received in 2024. These payments were reported across 655 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($10,968).
As a Medicare-enrolled provider, Chung has provided services to 3,711 Medicare beneficiaries, totaling 191,377 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Emerson, NJ
- Active Since 01/24/2006
- Last Updated 12/11/2012
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1083684088
Products in Payments
- Enbrel (Biological) $670.73
- XELJANZ (Drug) $639.62
- Cimzia (Drug) $577.48
- COSENTYX (Biological) $575.97
- EVENITY (Biological) $550.94
- STELARA (Biological) $537.37
- TALTZ (Drug) $476.09
- COSENTYX (Drug) $426.89
- Prolia (Biological) $407.26
- ORENCIA (Biological) $389.16
- SIMPONI ARIA (Biological) $359.92
- PURIFIED CORTROPHIN GEL (Drug) $338.04
- RINVOQ (Biological) $314.21
- BENLYSTA (Biological) $307.51
- TREMFYA (Drug) $261.54
- ACTHAR (Biological) $250.74
- Tymlos (Biological) $250.35
- KEVZARA (Drug) $214.84
- KRYSTEXXA (Biological) $186.64
- EUFLEXXA (Device) $160.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.